Suppr超能文献

钙、雌激素和孕激素在骨质疏松症治疗中的应用。

Calcium, estrogen, and progestin in the treatment of osteoporosis.

作者信息

Breslau N A

机构信息

University of Texas Southeastern Medical Center, Dallas.

出版信息

Rheum Dis Clin North Am. 1994 Aug;20(3):691-716.

PMID:7984785
Abstract

An adequate calcium intake is important to attain peak bone mass and to oppose that component of age-related bone loss due to insufficient intestinal calcium absorption. Calcium and appropriate vitamin D supplements are particularly important for preventing cortical bone loss and associated hip fractures in the elderly (Type II osteoporosis). Within the initial 5 years following menopause, there is an accelerated loss of trabecular bone from the spine and distal radius (Type I osteoporosis). At that time, estrogen replacement is most effective for preventing the rapid trabecular bone loss that could otherwise result in vertebral or Colles' fractures. During this early period of estrogen deficiency when excessive bone turnover is releasing large amounts of calcium into the circulation, supplemental calcium is ineffective. Progesterone, often given with estrogen to prevent endometrial carcinoma, may itself have a trophic influence on bone.

摘要

摄入足够的钙对于达到峰值骨量以及对抗因肠道钙吸收不足导致的与年龄相关的骨质流失部分非常重要。钙和适当的维生素D补充剂对于预防老年人的皮质骨丢失及相关髋部骨折(II型骨质疏松症)尤为重要。在绝经后的最初5年内,脊柱和桡骨远端的小梁骨会加速流失(I型骨质疏松症)。此时,雌激素替代疗法对于预防快速的小梁骨丢失最为有效,否则可能导致椎体骨折或Colles骨折。在雌激素缺乏的早期阶段,当过度的骨转换将大量钙释放到循环中时,补充钙是无效的。通常与雌激素一起使用以预防子宫内膜癌的孕激素本身可能对骨骼有营养作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验